Puma Biotechnology (PBYI) Shares Outstanding (Weighted Average) (2010 - 2026)

Puma Biotechnology has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $50.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 2.52% year-over-year to $50.8 million; the trailing twelve-month figure through Mar 2026 stood at $50.8 million (up 2.52% YoY), and the FY2025 full-year result was $50.0 million, up 2.8% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $50.8 million, up from $50.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $50.8 million in Q1 2026, with the low at $42.2 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $47.6 million across 5 years, with a median of $48.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) increased 11.61% — and 2025, when it grew 1.78%.
• Puma Biotechnology's Shares Outstanding (Weighted Average) stood at $44.7 million in 2022, then rose by 5.51% to $47.1 million in 2023, then advanced by 3.21% to $48.6 million in 2024, then gained by 2.8% to $50.0 million in 2025, then grew by 1.67% to $50.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $50.8 million (Q1 2026), $50.0 million (Q4 2025), and $49.9 million (Q3 2025), per Business Quant data.